Get started
ASTRAZENECA DRNASTRAZENECA DRNASTRAZENECA DRN

ASTRAZENECA DRN

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

A1ZN34 chart


Full chart

Key facts today

AstraZeneca lifted its annual sales and profit forecast for the second time this year.
Intron Health upgraded AstraZeneca to a 'Buy' rating from 'Hold' while maintaining its price target at 120 pounds sterling.
AstraZeneca's benralizumab is noted as a mid-stage drug in development for COPD management, alongside other drugs from Sanofi/Regeneron and GSK.
Analyze the impactAnalyze the impact

Key stats


Market capitalization
‪1.15 T‬ BRL
Dividend yield (indicated)
1.91%
Price to earnings Ratio (TTM)
2.585
Basic EPS (TTM)
24.126 BRL
Net income (FY)
‪29.65 B‬ BRL
Revenue (FY)
‪228.07 B‬ BRL
Shares float
‪1.47 B‬
Beta (1Y)
−0.11

About ASTRAZENECA PLC ORD USD0.25


Sector
Health Technology
CEO
Pascal Soriot
Headquarters
Cambridge
Website
astrazeneca.co.uk
Founded
1992
ISIN
BRA1ZNBDR003
FIGI
BBG00XX9GNT2
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

A1ZN34 news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

A1ZN34 highest yielding bonds


US46353AM0
ASTRAZENECA PLC 15/45
Yield to maturity
5.30%
Maturity date
Nov 16, 2045
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
5.29%
Maturity date
Sep 15, 2037
US46353AU2
ASTRAZENECA 18/48
Yield to maturity
5.27%
Maturity date
Aug 17, 2048
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.26%
Maturity date
Sep 18, 2042
A
US4636NAN3
ASTRAZEN.FI. 24/34
Yield to maturity
5.05%
Maturity date
Feb 26, 2034
US46353AZ1
ASTRAZENECA 21/51
Yield to maturity
4.99%
Maturity date
May 28, 2051
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.93%
Maturity date
Mar 3, 2033
US46353AX6
ASTRAZENECA 20/50
Yield to maturity
4.91%
Maturity date
Aug 6, 2050
A
US4636NAM5
ASTRAZEN.FI. 24/31
Yield to maturity
4.87%
Maturity date
Feb 26, 2031
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
4.77%
Maturity date
May 28, 2031
A
AZN5549115
AstraZeneca Finance LLC 4.9% 03-MAR-2030
Yield to maturity
4.75%
Maturity date
Mar 3, 2030

Explore more bonds 

Sparks


Curated watchlists where A1ZN34 is featured.

See all sparks